CD274 and colorectal carcinoma: To address the effect of combinations of agents on gefitinib-resistant CRC proliferation, we examined the effects of NDAT, LY294002, or gefitinib and their combination on the expression of PD-L1 and related genes in Colo_160224 cells (Figure 4C).